Overview
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 91 days late).
- 202514/07/2026
- 202408/07/2025
- 202315/07/2024
- 202203/07/2023
- 202114/10/2022
- 202030/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
National Health Fund (NFZ) contracts
Dreszczyk I Wspólnicy has been an NFZ healthcare provider since 2024. In 2026 it is performing 5 contracts with a total value of USD 0.00. All its contracts were worth USD 0.00 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Other services provided in pharmacies | wielkopolskie | 5 | USD 0.00 |
Ownership
| Owner |
|---|
Grzegorz Dreszczykage 50 |
Magdalena Dreszczykage 45 |
Barbara Fiklewicz Dreszczykage 83 |
Manner of representation
Each partner has the right to represent the company independently.
Barbara Fiklewicz Dreszczyk, Grzegorz Dreszczyk and Magdalena Dreszczyk – all partners share the same surname, so the structure looks family-owned.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1995-02-15.
84 1090 1359 0000 0001 2053 6488
05 1090 1359 0000 0001 0464 2326
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $121,298.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 21, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $105.1K$105,134 | Polski Fundusz Rozwoju S.A. | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,289$4,289 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,435$4,435 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Produkcyjno-Handlowe Apimexsp. z o.o. | $16,601,428.28 | apimex.pl | ||
| Fragalsp. z o.o. | $5,374,285.81 | aptekafragal.pl | ||
| Modrzewscysp. j. | $5,602,358.99 | aptekacentrum.lublin.pl | ||
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Gold Lionsp. z o.o. | $1,669,649.21 | goldlion.pl | ||
| Grupa Aptekarska Kujałowiczsp. j. | $1,452,484.91 | wga.pl | ||
| Rutkiewicz I Wspólnicysp. j. | – | aptekapoznan.com |
FAQ
Last updated: 2026-07-17